APC-300

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAPC-300
Drug Alias NameCPC-300APC-300
ClassificationSmall molecules
Mechanisms of ActionGTPase Ras modulatorsApoptosis stimulantsSignal transduction pathway inhibitors
TargetsGTPase Ras
Therapy Area/IndicationsProstatic NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColby Pharmaceutical Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesColby Pharmaceutical CoAdamis Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A